Nouveautés thérapeutiques dans la prise en charge des carcinoses péritonéales d'origine digestive : chirurgie de cytoréduction et chimiothérapie intrapériton&#x

详细信息    查看全文

• 作者：O. Glehen ; E. Cotte ; C. Brigand ; C. Arvieux ; A.C. Sayag-Beaujard and F.N. Gilly
• 关键词：Peritoneal carcinomatosis ; Hyperthermia ; Intraperitoneal chemotherapy ; Peritonectomy ; Cytoreductive surgery
• 刊名：La Revue de Medecine Interne
• 出版年：2006
• 出版时间：May 2006
• 年：2006
• 卷：27
• 期：5
• 页码：382-391
• 全文大小：317 K

文摘

Purpose. – Peritoneal carcinomatosis and particularly those from digestive origin has long been considered as an automatically terminal disease in abdominal cancer patients.<p>Current knowledge and key points. – Over the past decade, new locoregional treatments combining cytoreductive surgery, peritonectomy procedures with perioperative intraperitoneal chemotherapy (with or without hyperthermia) have been developed by specialized teams. Because of its high but acceptable mortality and morbidity, this aggressive but comprehensive therapeutic strategy requires accurate and strict patient's selection into multidisciplinary and specialized teams. It may allow prolonged survival and cure for patients with pseudomyxoma peritonei, peritoneal mesothelioma, carcinomatosis from colorectal or gastric cancer. Qualitative and quantitative prognostic indicators are needed to assess a patient's eligibility, including tumor histopathology, assessment of carcinomatosis extent or completeness of cytoreduction which appears to be the most important.<p>Perspectives. – Combination of cytoreductive surgery with perioperative intraperitoneal chemotherapy appears to be an adapted therapeutic approach for patients strictly selected, with peritoneal carcinomatosis. Phase III studies are now needed for the validation and the evaluation of the type of intraperitoneal chemotherapy.